2 results
Approved WMOCompleted
To demonstrate proof of concept, i.e. equivalent dispersal by both methods.
Approved WMOPending
The primary objective is to determine the efficacy of the neuroprotectant, nerinetide in:• Reducing global disability in participants with acute ischemic stroke (AIS)